• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Why Kodiak Sciences Shares Are Trading Lower By Around 20%? Here Are Other Stocks Moving In Thursday's Mid-Day Session

    3/28/24 2:08:52 PM ET
    $ABTS
    $AKAN
    $ALLG
    $ALT
    Computer Software: Programming Data Processing
    Technology
    Medicinal Chemicals and Botanical Products
    Health Care
    Get the next $ABTS alert in real time by email

    Shares of Kodiak Sciences Inc. (NASDAQ:KOD) fell sharply during Thursday’s session after the company reported a wider-than-expected fourth-quarter loss.

    Kodiak Sciences posted a quarterly loss of $1.13 per share, compared to market expectations for a loss of 77 cents per share.

    Kodiak Sciences shares dipped 19.9% to $5.97 on Thursday.

    Here are some other stocks moving in today's mid-day session.

    Gainers

    • Avalo Therapeutics, Inc. (NASDAQ:AVTX) shares jumped 430% to $25.35 after the company announced it acquired a Phase 2-ready anti-IL-1β mAb, which it refers to as AVTX-009, through the acquisition of privately held AlmataBio. The company also announced a private placement financing of up to $185 million.
    • Xilio Therapeutics, Inc. (NASDAQ:XLO) gained 146% to $1.58 after the company announced an exclusive license agreement with Gilead Sciences for a tumor-activated IL-12 program. The company announced a $11.3 million private placement equity financing.
    • Biodexa Pharmaceuticals Plc (NASDAQ:BDRX) shares climbed 80% to $1.5395. Biodexa's MTX110 showed promise in extending life expectancy against aggressive brain cancers.
    • Ontrak, Inc. (NASDAQ:OTRK) gained 55% to $0.9239.
    • Binah Capital Group, Inc. (NASDAQ:BCG) gained 48% to $14.05 after dipping more than 20% on Wednesday.
    • Kidpik Corp. (NASDAQ:PIK) gained 40.7% to $4.5999. Kidpik recently regained compliance with the Nasdaq minimum bid price requirement.
    • Allego N.V. (NASDAQ:ALLG) rose 32.8% to $1.7650.
    • Akanda Corp. (NASDAQ:AKAN) gained 28% to $0.2053 after the company announced a plan to evaluate opportunities in Bitcoin, Blockchain and AI applications in the cannabis industry.
    • Destiny Tech100 Inc. (NASDAQ:DXYZ) rose 26% to $22.15.
    • REX American Resources Corporation (NYSE:REX) gained 23.2% to $54.15 following upbeat earnings.
    • Nutriband Inc. (NASDAQ:NTRB) gained 23% to $4.98. Nutriband recently provided a clinical and regulatory path overview for its AVERSA Fentanyl patch.
    • Summit Therapeutics Inc. (NASDAQ:SMMT) gained 22.8% to $4.6050.
    • CERo Therapeutics Holdings, Inc. (NASDAQ:CERO) gained 22.7% to $2.00.
    • Hut 8 Corp. (NASDAQ:HUT) gained 20.4% to $11.87. Hut 8 Corp reported revenue of C$60.6 million for the six months ended Dec. 31, 2023.
    • Matterport, Inc. (NASDAQ:MTTR) rose 16.8% to $2.2802.
    • RH (NYSE:RH) rose 16.2% to $344.99 following the release of quarterly results. RH posted weaker-than-expected results for its fourth quarter, but issued upbeat forecast.
    • Cazoo Group Ltd (NASDAQ:CZOO) gained 15.5% to $14.52 after jumping over 100% on Wednesday.
    • Sutro Biopharma, Inc. (NASDAQ:STRO) surged 14.4% to $5.64. Oppenheimer analyst Jay Olson maintained Sutro Biopharma with an Outperform and maintained a $10 price target.
    • Kintara Therapeutics, Inc. (NASDAQ:KTRA) shares rose 14.1% to $0.1021. Kintara Therapeutics announced expansion of REM-001 clinical study to include patients on pembrolizumab.
    • Nikola Corporation (NASDAQ:NKLA) gained 12.7% to $1.0250.
    • OPKO Health, Inc. (NASDAQ:OPK) climbed 12.1% to $1.1996. Labcorp announced acquisition of select assets of BioReference Health's Diagnostics Business.
    • Altimmune, Inc. (NASDAQ:ALT) climbed 11.4% to $9.90. Altimmune recently released lean mass preservation data for pemvidutide and worse-than-expected fourth-quarter FY23 earnings.
    • Marathon Digital Holdings, Inc. (NASDAQ:MARA) gained 10.4% to $24.37.
    • Ginkgo Bioworks Holdings, Inc. (NYSE:DNA) rose 7.1% to $1.1786. Ginkgo Bioworks announced that it has been awarded a contract for up to $6 million from the Defense Advanced Research Projects Agency.
    • The Estée Lauder Companies Inc. (NYSE:EL) gained 5.4% to $152.85 after B of A Securities upgraded the stock from Neutral to Buy and raised its price target from $160 to $170.

    Losers

    • Primech Holdings Ltd. (NASDAQ:PMEC) shares fell 46.7% to $2.07 after the company issued financial updates and corporate highlights for the six months ended Sept. 30, 2023.
    • Gamida Cell Ltd. (NASDAQ:GMDA) fell 28.1% to $0.0427. Gamida Cell shares dipped over 82% on Wednesday after the company reported fourth-quarter results and disclosed the commencement of a restructuring process.
    • Data Storage Corporation (NASDAQ:DTST) dipped 24% to $5.81 following fourth-quarter results.
    • urban-gro, Inc. (NASDAQ:UGRO) declined 22.9% to $1.3992 after the company reported worse-than-expected fourth-quarter financial results.
    • Presto Automation Inc. (NASDAQ:PRST) fell 22% to $0.1493. Presto Automation recently entered securities purchase agreements relating to the issuance and sale of 4.8 million shares
    • Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP) dipped 19.6% to $0.2629. Tonix Pharmaceuticals announced pricing of $4.4 million registered direct offering.
    • MillerKnoll, Inc. (NASDAQ:MLKN) shares fell 17.2% to $25.28 as the company reported downbeat sales for its third quarter and issued weak guidance for the fourth quarter.
    • Sezzle Inc. (NASDAQ:SEZL) fell 16.6% to $77.13.
    • NuCana plc (NASDAQ:NCNA) fell 16.3% to $0.2616. NuCana announced a plan to implement 1-for-25 ADS ratio change.
    • SOBR Safe, Inc. (NASDAQ:SOBR) fell 13.7% to $0.4460 after gaining 12% on Wednesday.
    • Murano Global Investments Plc (NASDAQ:MRNO) fell 13% to $12.97.
    • 22nd Century Group, Inc. (NASDAQ:XXII) fell 12.5% to $ 0.1151 as the company posted fourth-quarter results and announced stock split of 1-for-16.
    • MicroStrategy Incorporated (NASDAQ:MSTR) declined 10.9% to $1,710.01.
    • Hitek Global Inc. (NASDAQ:HKIT) fell 10.3% to $1.56 after gaining over 22% on Wednesday.
    • Movella Holdings Inc. (NASDAQ:MVLA) fell 10.2% to $0.0678 after dipping 20% on Wednesday.
    • Abits Group Inc. (NASDAQ:ABTS) fell 10.2% to $0.70.
    • Reddit, Inc. (NYSE:RDDT) fell 9.4% to $52.32.
    • Braze, Inc. (NASDAQ:BRZE) dipped 9.3% to $45.90 after the company issued soft EPS guidance for FY25.
    • The Chemours Company (NYSE:CC) shares dropped 6.2% to $27.09 after the company reported fourth-quarter results. The company also said it identified four material weaknesses amid its internal control over financial reporting.
    • GCT Semiconductor Holding Inc, (NYSE:GCTS) fell 5.1% to $41.77 amid volatility following the company's recently completed business combination with Concord Acquisition Corp III and NYSE debut.
    • Carnival Corporation & plc (NYSE:CCL) fell 4% to $16.52. Carnival posted a narrower-than-expected loss for its first quarter on Wednesday.

     

    Now Read This: Jim Cramer Likes Crown Castle, But Can't Recommend Archer Aviation: It Has 'No Earnings Power'

    Get the next $ABTS alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $ABTS
    $AKAN
    $ALLG
    $ALT

    CompanyDatePrice TargetRatingAnalyst
    Altimmune Inc.
    $ALT
    4/24/2026$2.50Sell → Neutral
    Goldman
    Reddit Inc.
    $RDDT
    4/21/2026$200.00Buy
    DA Davidson
    Avalo Therapeutics Inc.
    $AVTX
    4/9/2026$48.00Outperform
    Wolfe Research
    Summit Therapeutics Inc.
    $SMMT
    4/8/2026$45.00Buy
    Stifel
    Sutro Biopharma Inc.
    $STRO
    4/7/2026$38.00Outperform
    Leerink Partners
    Reddit Inc.
    $RDDT
    4/7/2026$149.00Equal Weight
    Wells Fargo
    Sezzle Inc.
    $SEZL
    4/6/2026$85.00Outperform
    Keefe Bruyette
    Avalo Therapeutics Inc.
    $AVTX
    4/6/2026$52.00Mkt Outperform
    Citizens
    More analyst ratings

    $ABTS
    $AKAN
    $ALLG
    $ALT
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 4 filed by Weinstein Joshua Ian

    4 - CARNIVAL CORP (0000815097) (Issuer)

    4/23/26 11:37:29 AM ET
    $CCL
    Marine Transportation
    Consumer Discretionary

    SEC Form 4 filed by Miguez Enrique

    4 - CARNIVAL CORP (0000815097) (Issuer)

    4/23/26 11:36:33 AM ET
    $CCL
    Marine Transportation
    Consumer Discretionary

    SEC Form 4 filed by Ljoen Lars Jakob

    4 - CARNIVAL CORP (0000815097) (Issuer)

    4/23/26 11:35:09 AM ET
    $CCL
    Marine Transportation
    Consumer Discretionary

    $ABTS
    $AKAN
    $ALLG
    $ALT
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Farrell Sarah E bought $1,388,730 worth of shares (10,500 units at $132.26) (SEC Form 4)

    4 - Reddit, Inc. (0001713445) (Issuer)

    3/17/26 7:20:55 PM ET
    $RDDT
    EDP Services
    Technology

    Chief Financial Officer Weaver Gregory L bought $17,700 worth of shares (5,000 units at $3.54), increasing direct ownership by 22% to 28,078 units (SEC Form 4)

    4 - Altimmune, Inc. (0001326190) (Issuer)

    3/9/26 7:05:04 AM ET
    $ALT
    Biotechnology: Pharmaceutical Preparations
    Health Care

    President and CEO Durso Jerome Benedict bought $70,790 worth of shares (20,000 units at $3.54), increasing direct ownership by 160% to 32,500 units (SEC Form 4)

    4 - Altimmune, Inc. (0001326190) (Issuer)

    3/9/26 7:00:05 AM ET
    $ALT
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ABTS
    $AKAN
    $ALLG
    $ALT
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Altimmune upgraded by Goldman with a new price target

    Goldman upgraded Altimmune from Sell to Neutral and set a new price target of $2.50

    4/24/26 7:59:47 AM ET
    $ALT
    Biotechnology: Pharmaceutical Preparations
    Health Care

    DA Davidson initiated coverage on Reddit with a new price target

    DA Davidson initiated coverage of Reddit with a rating of Buy and set a new price target of $200.00

    4/21/26 7:34:27 AM ET
    $RDDT
    EDP Services
    Technology

    Wolfe Research initiated coverage on Avalo Therapeutics with a new price target

    Wolfe Research initiated coverage of Avalo Therapeutics with a rating of Outperform and set a new price target of $48.00

    4/9/26 8:40:45 AM ET
    $AVTX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ABTS
    $AKAN
    $ALLG
    $ALT
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    April 17, 2023 - FDA Approves Cell Therapy for Patients with Blood Cancers to Reduce Risk of Infection Following Stem Cell Transplantation

    For Immediate Release: April 17, 2023 Today, the U.S. Food and Drug Administration approved Omisirge (omidubicel-onlv), a substantially modified allogeneic (donor) cord blood-based cell therapy to quicken the recovery of neutrophils (a subset of white blood cells) in the body and reduce the risk of infection. The product is intended for use in adults and pediatric patients 12 years and older with blood cancers p

    4/17/23 1:02:15 PM ET
    $GMDA
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    December 23, 2021 - FDA Authorizes Marketing of Tobacco Products that Help Reduce Exposure to and Consumption of Nicotine for Smokers Who Use Them

    For Immediate Release: December 23, 2021 Today, the U.S. Food and Drug Administration authorized the marketing of 22nd Century Group Inc.’s “VLN King” and “VLN Menthol King” combusted, filtered cigarettes as modified risk tobacco products (MRTPs), which help reduce exposure to, and consumption of, nicotine for smokers who use them. These are the first combusted cigarettes to be authorized as MRTPs and the second

    12/23/21 9:06:12 AM ET
    $XXII
    Medicinal Chemicals and Botanical Products
    Health Care

    FDA Approval for DEXTROAMP SACCHARATE, AMP ASPARTATE, DEXTROAMP SULFATE AND AMP SULFATE

    Submission status for RHODES PHARMS's drug DEXTROAMP SACCHARATE, AMP ASPARTATE, DEXTROAMP SULFATE AND AMP SULFATE (ORIG-1) with active ingredient AMPHETAMINE ASPARTATE ; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE has changed to 'Approval' on 01/13/2021. Application Category: ANDA, Application Number: 213111, Application Classification:

    1/18/21 5:24:40 AM ET
    $RH
    Other Specialty Stores
    Consumer Discretionary

    $ABTS
    $AKAN
    $ALLG
    $ALT
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Carnival Corporation Expands Mexico Maritime Cadet Apprenticeship Program

    World's largest cruise company expands partnership with Maritime & Port University of Mexico to offer onboard training opportunities with Princess Cruises for maritime students in Mexico Addendum signed during Seatrade Cruise Global reinforces the company's proactive approach to supporting maritime education and cultivating a skilled, global maritime workforceMIAMI, April 23, 2026 /PRNewswire/ -- Carnival Corporation & plc ((NYSE/LSE: CCL, NYSE:CUK), the world's largest cruise company, expanded its maritime cadet apprenticeship program with Princess Cruises and Maritime & Port University of Mexico, broadening onboard training opportunities for Mexican maritime students and supporting future

    4/23/26 9:30:00 AM ET
    $CCL
    $CUK
    Marine Transportation
    Consumer Discretionary

    Star Princess Named to Condé Nast Traveler's Prestigious 2026 Hot List

    Princess Cruises' Newest Sphere Class Ship Recognized Among the World's Best New Cruise ShipsFORT LAUDERDALE, Fla., April 23, 2026 /PRNewswire/ -- Princess Cruises is proud to announce that Star Princess has been named to Condé Nast Traveler's 2026 Hot List, a highly regarded annual selection recognizing the best new and newly transformed travel experiences around the world. Celebrating its 30th edition, the Condé Nast Traveler Hot List is curated by the publication's global editorial team and honors standout hotels, resorts, restaurants, and cruise ships that raise the bar for

    4/23/26 9:00:00 AM ET
    $CCL
    $CUK
    Marine Transportation
    Consumer Discretionary

    22nd Century Group Expands Reduced Nicotine Platform Through New Testing Services Agreement with North Carolina State University

    MOCKSVILLE, N.C., April 23, 2026 (GLOBE NEWSWIRE) -- 22nd Century Group, Inc. (NASDAQ:XXII), a tobacco products company focused on nicotine reduction and plant biotechnology, today announced corporate updates regarding a new testing services agreement with North Carolina State University aimed at validating tobacco varieties featuring improved leaf quality and increased crop yields with the same low-nicotine content. The initiative builds upon 22nd Century's proprietary reduced nicotine content technology platform, which utilizes advanced plant breeding and biotechnology to reduce nicotine content in tobacco to minimally addictive levels. The Company's reduced nicotine tobacco is the foun

    4/23/26 7:50:00 AM ET
    $XXII
    Medicinal Chemicals and Botanical Products
    Health Care

    $ABTS
    $AKAN
    $ALLG
    $ALT
    SEC Filings

    View All

    SEC Form 424B5 filed by Altimmune Inc.

    424B5 - Altimmune, Inc. (0001326190) (Filer)

    4/23/26 9:29:55 PM ET
    $ALT
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form DEFA14A filed by Reddit Inc.

    DEFA14A - Reddit, Inc. (0001713445) (Filer)

    4/23/26 4:11:08 PM ET
    $RDDT
    EDP Services
    Technology

    SEC Form DEF 14A filed by Reddit Inc.

    DEF 14A - Reddit, Inc. (0001713445) (Filer)

    4/23/26 4:10:19 PM ET
    $RDDT
    EDP Services
    Technology

    $ABTS
    $AKAN
    $ALLG
    $ALT
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G filed by CERo Therapeutics Holdings Inc.

    SC 13G - CERO THERAPEUTICS HOLDINGS, INC. (0001870404) (Subject)

    12/13/24 7:18:17 PM ET
    $CERO
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    Amendment: SEC Form SC 13D/A filed by Estee Lauder Companies Inc.

    SC 13D/A - ESTEE LAUDER COMPANIES INC (0001001250) (Subject)

    12/10/24 6:06:03 PM ET
    $EL
    Package Goods/Cosmetics
    Consumer Discretionary

    Amendment: SEC Form SC 13D/A filed by Estee Lauder Companies Inc.

    SC 13D/A - ESTEE LAUDER COMPANIES INC (0001001250) (Subject)

    12/9/24 5:30:41 PM ET
    $EL
    Package Goods/Cosmetics
    Consumer Discretionary

    $ABTS
    $AKAN
    $ALLG
    $ALT
    Leadership Updates

    Live Leadership Updates

    View All

    urban-gro, Inc. (Nasdaq: UGRO) — Sri Lanka Cricket Confirms July 10 – August 5, 2026 and Four Venues for Lanka Premier League Season 6; Tournament Conducted in Partnership with UGRO Subsidiary IPG Group

    LAFAYETTE, Colo., April 23, 2026 (GLOBE NEWSWIRE) -- urban-gro, Inc. (NASDAQ:UGRO) ("urban-gro" or the "Company"), operating through Flash Sports & Media, Inc., today noted the official announcement by Sri Lanka Cricket ("SLC") confirming the dates, venues, and player-registration timeline for Lanka Premier League ("LPL") Season 6. The tournament will run from July 10 to August 5, 2026, and is owned by SLC and conducted in partnership with Innovative Production Group FZ, LLC ("IPG"), the event rights holder. The Company participates in the tournament through its subsidiary, IPG under existing commercial arrangements. Season 6 — By the Numbers Tournament windowJuly 10 – August 5, 2026 (

    4/23/26 7:05:00 AM ET
    $UGRO
    Industrial Specialties
    Consumer Discretionary

    Xilio Therapeutics Appoints Cheryl R. Blanchard, Ph.D. to its Board of Directors

    WALTHAM, Mass., April 16, 2026 (GLOBE NEWSWIRE) -- Xilio Therapeutics, Inc. (NASDAQ:XLO), a clinical-stage biotechnology company discovering and developing masked immuno-oncology therapies for people living with cancer, today announced the appointment of Cheryl R. Blanchard, Ph.D. to the company's board of directors. The company also announced that Christina Rossi has stepped down from its board of directors, effective April 15, 2026. "Cheryl brings over three decades of leadership experience advancing the development of innovative products across biologics, small molecules and medical devices, and I am pleased to welcome her to the board," said Sara Bonstein, chair of the board of direct

    4/16/26 7:30:00 AM ET
    $ANIK
    $XLO
    Medical/Dental Instruments
    Health Care
    Biotechnology: Pharmaceutical Preparations

    urban-gro, Inc. (Nasdaq: UGRO) Announces Lanka Premier League Season 6 — Potential Record 600-Player Pool, World-Class Marquee Talent, and Expected Appointment of Chris Gayle as Global Brand Ambassador

    LAFAYETTE, Colo., April 13, 2026 (GLOBE NEWSWIRE) -- urban-gro, Inc. (NASDAQ:UGRO) ("urban-gro" or the "Company"), operating through Flash Sports & Media, Inc., a vertically integrated sports, media, and experiential platform, today announced that Lanka Premier League ("LPL") Season 6 — executed via its subsidiary Innovative Production Group FZ, LLC ("IPG") platform — is expecting record-breaking expansion. Season 6 is projected to feature the largest-ever LPL player registration pool of 500 to 600 athletes expected to be drawn from the world's top cricketing nations, elevated by a marquee roster of global superstars and the expected appointment of T20 legend Chris Gayle as official Brand

    4/13/26 7:05:00 AM ET
    $UGRO
    Industrial Specialties
    Consumer Discretionary

    $ABTS
    $AKAN
    $ALLG
    $ALT
    Financials

    Live finance-specific insights

    View All

    Chemours Announces Dates for First Quarter 2026 Earnings Release and Webcast Conference Call

    WILMINGTON, Del., April 21, 2026 /PRNewswire/ -- The Chemours Company ("Chemours" or "the Company") (NYSE:CC) today announced that the Company expects to issue its first quarter 2026 financial results after market on Tuesday, May 5, 2026.The Company expects to hold its conference call to discuss its first quarter 2026 financial results at 8:00 a.m. Eastern Time on Wednesday, May 6, 2026. The call is open to the public and can be accessed via the webcast information below. The webcast and materials can be accessed by visiting the "Events and Presentations" section of the Investor Relations section of Chemours' website at investors.chemours.com.Conference Call: Please visit investors.chemours.

    4/21/26 4:30:00 PM ET
    $CC
    Major Chemicals
    Industrials

    OPKO Health to Report First Quarter 2026 Financial Results on April 28, 2026

    MIAMI, April 21, 2026 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (NASDAQ:OPK) plans to report operating and financial results for the three months ended March 31, 2026 after the close of the U.S. financial markets on Tuesday, April 28, 2026. OPKO's senior management will provide a business update and discuss results as well as financial guidance during a conference call and live audio webcast on April 28th beginning at 4:30 p.m. Eastern time. CONFERENCE CALL & WEBCAST INFORMATION OPKO encourages participants to pre-register for the conference call using this link. Callers who pre-register will receive a unique PIN to gain immediate access to the call and bypass the live operator. Participants

    4/21/26 4:05:00 PM ET
    $OPK
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Hut 8 Schedules First Quarter 2026 Earnings Release and Conference Call

    MIAMI, April 17, 2026 /PRNewswire/ -- Hut 8 Corp. ((Nasdaq, TSX:HUT) ("Hut 8" or the "Company"), an energy infrastructure platform integrating power, digital infrastructure, and compute at scale to fuel next-generation, energy-intensive use cases, today announced it will release financial results for the first quarter of 2026 before the market opens on May 6, 2026. The Company will host a conference call and webcast to review the results on the same day at 8:30 a.m. ET. Conference Call and Webcast DetailsDate: Wednesday, May 6, 2026Time: 8:30 a.m. ETTo register for the webcast,

    4/17/26 6:30:00 AM ET
    $HUT
    Finance: Consumer Services
    Finance

    $ABTS
    $AKAN
    $ALLG
    $ALT
    Insider purchases explained

    Analytical look into recent insider purchases

    View All

    Insider Analysis: Purchase at urban-gro Inc. on Jun 6

    Urban-gro Inc. saw an interesting insider purchase on June 6, 2024, when Wilks Lewis bought $29,000 worth of shares, acquiring 20,000 units at a price of $1.45 per unit. This transaction increased Lewis' direct ownership by 12% to 184,108 units, as reported in SEC Form 4. Insider transactions like this can provide valuable insights for investors, indicating confidence in the company's future prospects. Analyzing the insider activity surrounding Urban-gro Inc., we can observe several transactions that may reveal patterns or insights. Looking back at previous filings, on September 1, 2023, Wilks Lewis purchased $10,300 worth of shares, acquiring 10,000 units at $1.03 per unit. This

    6/10/24 12:49:49 AM ET
    $UGRO
    Industrial Specialties
    Consumer Discretionary